Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice.

Marta Calvo MoyaYago González LamaBelén Ruíz AntoránIgnacio Omella UsietoIsmael El Hajra MartinezElena Santos PérezBelén Menchén VisoVirginia Matallana RoyoIrene González PartidaRocío de Lucas Tellez de MenesesPablo Bella CastilloMacarena González RodriguezMaría Isabel Vera Mendoza

Published in: Crohn's & colitis 360 (2023)

ADA intensification to 80 mg eow was safe, effective, and did not increase drug costs versus standard intensification to 40 mg ew in our experience.

Keyphrases

clinical practice
rheumatoid arthritis
emergency department
clinical trial
systemic lupus erythematosus
disease activity
smoking cessation
placebo controlled